AdipoPharma is a startup based in France, most recent round Pre-Seed.
AdipoPharma is a startup based in France. Its most recent tracked round is Pre-Seed.
AdipoPharma is a French biotechnology company developing a first-in-class therapeutic peptide, PATAS, which targets adipocyte cells to treat insulin resistance, type 2 diabetes, and related metabolic comorbidities.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.